Literature DB >> 16256409

The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.

Chin-Song Lu, Erik J Simons, Yah-Huei Wu-Chou, Alessio Di Fonzo, Hsiu-Chen Chang, Rou-Shayn Chen, Yi-Hsin Weng, Christan F Rohé, Guido J Breedveld, Nobutaka Hattori, Thomas Gasser, Ben A Oostra, Vincenzo Bonifati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16256409     DOI： 10.1016/j.parkreldis.2005.09.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  16 in total

1.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.

Authors:  Alessio Di Fonzo; Yah-Huei Wu-Chou; Chin-Song Lu; Marina van Doeselaar; Erik J Simons; Christan F Rohé; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Nicola Vanacore; Guido J Breedveld; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2006-04-22       Impact factor: 2.660

2.  The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

Authors:  E K Tan; Y Zhao; L Skipper; M G Tan; A Di Fonzo; L Sun; S Fook-Chong; S Tang; E Chua; Y Yuen; L Tan; R Pavanni; M C Wong; P Kolatkar; C S Lu; V Bonifati; J J Liu
Journal:  Hum Genet       Date:  2006-09-30       Impact factor: 4.132

3.  LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.

Authors:  Daniel Kam Yin Chan; Ping Wing Ng; Vincent Mok; Jonas Yeung; Zhi Ming Fang; Raymond Clarke; Edward Leung; Lawrence Wong
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

4.  A study of six point mutation analysis of LRRK2 gene in Chinese mainland patients with Parkinson's disease.

Authors:  Z X Hu; D T Peng; M Cai; J L Pu; X G Lei; X Z Yin; Z Y Ou-Yang; W Luo; B R Zhang
Journal:  Neurol Sci       Date:  2011-01-14       Impact factor: 3.307

Review 5.  PARK8 LRRK2 parkinsonism.

Authors:  Kristoffer Haugarvoll; Zbigniew K Wszolek
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

6.  Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

Authors:  Min Liu; Samantha A Bender; Gregory D Cuny; Woody Sherman; Marcie Glicksman; Soumya S Ray
Journal:  Biochemistry       Date:  2013-03-01       Impact factor: 3.162

Review 7.  LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.

Authors:  Vincenzo Bonifati
Journal:  Neurochem Res       Date:  2007-04-18       Impact factor: 3.996

8.  The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population.

Authors:  Chin-Song Lu; Yah-Huei Wu-Chou; Marina van Doeselaar; Erik J Simons; Hsiu-Chen Chang; Guido J Breedveld; Alessio Di Fonzo; Rou-Shayn Chen; Yi-Hsin Weng; Szu-Chia Lai; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2008-08-21       Impact factor: 2.660

Review 9.  Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.

Authors:  Payal N Gandhi; Shu G Chen; Amy L Wilson-Delfosse
Journal:  J Neurosci Res       Date:  2009-05-01       Impact factor: 4.164

Review 10.  Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician.

Authors:  Una-Marie Sheerin; Henry Houlden; Nicholas W Wood
Journal:  Mov Disord Clin Pract       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.